Latest Breaking News On - Society for nuclear medicine - Page 1 : comparemela.com

Nuclear Medicine Highlighted In Documentary Series

Reston, VA-The field of nuclear medicine is in the spotlight this season on the TV documentary Jobs of Tomorrow. The series, hosted by Kristin Marand

Helen nadelKristin marandSociety for nuclear medicineNuclear medicineMolecular imaging

TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation

TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation
balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.

CaliforniaUnited statesJapanSan franciscoAustraliaBelgiumSwitzerlandMelbourneVictoriaCanadaAustralianKyahn williamsonRichard valeixCdx pixclaraSteven chilinskiDavidn cade

Perspective Therapeutics Reports Second Quarter Fiscal 2023 Results and Recent Business Highlights

Perspective Therapeutics Reports Second Quarter Fiscal 2023 Results and Recent Business Highlights
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

University of iowaIowaUnited statesCoralvilleAustraliaRichlandAustralianAmericanAraxes pharmaChuck padalaThijs spoorGeoffrey johnsonNycomed amershamPardes biosciencesGe healthcareInternational symposium on radiopharmaceutical sciences

Fusion Pharmaceuticals Announces Second Quarter 2023 Financial Results and Clinical Program Updates

Fusion Pharmaceuticals Announces Second Quarter 2023 Financial Results and Clinical Program Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

BostonMassachusettsUnited statesJohn valliantAmanda craySociety of nuclear medicineInvestor relations corporate communicationsFusion pharmaceuticalsPrnewswire fusion pharmaceuticals incNasdaqFusion pharmaceuticals incDrug administrationAstrazenecaSociety for nuclear medicineNiowave incNuclear medicine

Fusion Pharmaceuticals has tons of upside, says Raymond James

Raymond James analyst Rahul Sarugaser maintained an “Outperform” rating on Fusion Pharmaceuticals in a Tuesday client report, saying the company is breaking new ground in cancer research.

John valliantRaymond jamesRahul sarugaserSociety for nuclear medicineFusion pharmaceuticalsFusion pharmaceuticals stockFusion pharmaceuticals stock quoteMonday phaseNuclear medicineMolecular imaging